Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Straus

Showing results (111-120 of 215) with videos related to

Pageof 22
Sort By:
Cancer|April 1, 1993
Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized studyJ Yahalom, G Varsos, Z Fuks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious DiseasesD J Straus, J Huang, M A Testa, et al.
American Journal of Clinical Oncology|April 1, 1983
Infusional chemotherapy and cyclic radiation therapy in inoperable esophageal and gastric cardia carcinomaA Abitbol, M J Straus, G Franklin, et al.
Cancer|November 15, 1987
Generalized lymphadenopathy with morphologic features of Castleman's disease in an HIV-positive manD A Lowenthal, D A Filippa, M E Richardson, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 10, 2018
Real-world analysis of cost, health care resource utilization, and supportive care in Hodgkin lymphoma patients with frontline failureMachaon Bonafede, Joseph Feliciano, Qian Cai, et al.
Chest|May 16, 2000
Abnormal flow volume loops in patients with intrathoracic Hodgkin's diseaseN J Vander Els, F Sorhage, A M Bach, et al.
Cancer|March 17, 2007
Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphomaDavid J Straus, Madeleine Duvic, Timothy Kuzel, et al.
Cancer Treatment Reports|March 1, 1981
Combination chemotherapy salvage of heavily pretreated patients with Hodgkin's disease: an analysis of prognostic factors in two chemotherapy trials and the literatureD J Straus, S Passe, B Koziner, et al.
The American Journal of Medicine|February 1, 1987
Non-Hodgkin's lymphomas: characteristics of long-term survivors following conservative treatmentD J Straus, J J Gaynor, P H Leiberman, et al.
Leukemia & Lymphoma|August 23, 2006
Pegylated interferon plus rituximab in advanced stage, indolent lymphoma: is there CD20 antigen upregulation?Carol S Portlock, Owen A O'Connor, David J Straus, et al.
Pageof 22

Showing results (111-120 of 215) with videos related to

Sort By:
Pageof 22
Cancer|April 1, 1993
Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Results of a prospective randomized studyJ Yahalom, G Varsos, Z Fuks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious DiseasesD J Straus, J Huang, M A Testa, et al.
American Journal of Clinical Oncology|April 1, 1983
Infusional chemotherapy and cyclic radiation therapy in inoperable esophageal and gastric cardia carcinomaA Abitbol, M J Straus, G Franklin, et al.
Cancer|November 15, 1987
Generalized lymphadenopathy with morphologic features of Castleman's disease in an HIV-positive manD A Lowenthal, D A Filippa, M E Richardson, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 10, 2018
Real-world analysis of cost, health care resource utilization, and supportive care in Hodgkin lymphoma patients with frontline failureMachaon Bonafede, Joseph Feliciano, Qian Cai, et al.
Chest|May 16, 2000
Abnormal flow volume loops in patients with intrathoracic Hodgkin's diseaseN J Vander Els, F Sorhage, A M Bach, et al.
Cancer|March 17, 2007
Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphomaDavid J Straus, Madeleine Duvic, Timothy Kuzel, et al.
Cancer Treatment Reports|March 1, 1981
Combination chemotherapy salvage of heavily pretreated patients with Hodgkin's disease: an analysis of prognostic factors in two chemotherapy trials and the literatureD J Straus, S Passe, B Koziner, et al.
The American Journal of Medicine|February 1, 1987
Non-Hodgkin's lymphomas: characteristics of long-term survivors following conservative treatmentD J Straus, J J Gaynor, P H Leiberman, et al.
Leukemia & Lymphoma|August 23, 2006
Pegylated interferon plus rituximab in advanced stage, indolent lymphoma: is there CD20 antigen upregulation?Carol S Portlock, Owen A O'Connor, David J Straus, et al.
Pageof 22